Published in Br J Cancer on February 19, 2008
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer (2011) 6.32
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta (2012) 1.26
Mitochondria and energetic depression in cell pathophysiology. Int J Mol Sci (2009) 0.95
Relationship between COX-2 and cell cycle-regulatory proteins in patients with esophageal squamous cell carcinoma. World J Gastroenterol (2010) 0.83
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival. Gastric Cancer (2015) 0.81
Clinicopathological Differences and Prognostic Value of Hypoxia-Inducible Factor-2α Expression for Gastric Cancer: Evidence From Meta-Analysis. Medicine (Baltimore) (2016) 0.75
What's wrong with Bonferroni adjustments. BMJ (1998) 19.89
Cancer burden in the year 2000. The global picture. Eur J Cancer (2001) 10.47
Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol (2003) 8.12
Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg (1998) 4.95
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 4.27
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer (2001) 3.10
Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res (2003) 2.93
Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res (2005) 2.78
Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer (2001) 1.96
Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell (2005) 1.89
Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res (1996) 1.84
Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res (2004) 1.62
Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res (2003) 1.60
Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis (2003) 1.54
HIF-1 and HIF-2: working alone or together in hypoxia? J Clin Invest (2007) 1.48
Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol (2003) 1.29
Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer (2002) 1.27
Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther (2004) 1.16
Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer (2006) 1.15
Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer (2002) 1.14
Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer (2005) 1.13
Prognostic significance of erythropoietin expression in human endometrial carcinoma. Cancer (2004) 1.09
Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate (2006) 1.09
Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles. Adv Exp Med Biol (2003) 1.08
Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol (2003) 1.08
Functional erythropoietin autocrine loop in melanoma. Am J Pathol (2005) 1.06
Is gastric cancer preventable? Gut (2004) 1.06
Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Br J Cancer (2007) 0.91
Hypoxia-inducible factors and cancer. Clin Transl Oncol (2007) 0.88
Apoptosis and proliferation in Helicobacter pylori-associated gastric intestinal metaplasia. Aliment Pharmacol Ther (2001) 0.88
Hypoxia-inducible factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas. Appl Immunohistochem Mol Morphol (2006) 0.86
Re: Levels of hypoxia-inducible factor-1alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 0.85
Glucose transporter 1 (GLUT1) expression is associated with intestinal type of gastric carcinoma. J Korean Med Sci (2000) 0.82
Expression of hypoxia inducible factor-1alpha and 2alpha in genetically distinct early renal cortical tumors. J Urol (2006) 0.82
Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci U S A (1982) 2.20
Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest (1998) 1.66
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. Clin Oncol (R Coll Radiol) (2013) 1.66
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention. BMJ (2010) 1.53
Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol (1975) 1.46
On reducing the frequency of severe abruptio placentae. Am J Obstet Gynecol (1991) 1.44
The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol (1996) 1.42
RAPPER: the radiogenomics of radiation toxicity. Clin Oncol (R Coll Radiol) (2013) 1.42
Desmoplastic small round cell tumour: a review of literature and treatment options. Surg Oncol (2008) 1.27
Chromosomal localization of human haemoglobin structural genes. Nature (1972) 1.26
The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol (1984) 1.22
Swallowing food without chewing; a simple way to reduce postprandial glycaemia. Br J Nutr (1986) 1.22
The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc Natl Acad Sci U S A (1999) 1.20
TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood (1999) 1.19
Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation. Br J Cancer (2012) 1.19
Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. Br J Cancer (2011) 1.18
Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer (2006) 1.15
Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol (1991) 1.15
Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer (2005) 1.13
Head and neck cancer--Part 2: Treatment and prognostic factors. BMJ (2010) 1.13
Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int (2001) 1.13
Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: possible implications for the dietary management of diabetes mellitus. Clin Sci (Lond) (1987) 1.11
Changes in gene expression after temporary renal ischemia. Kidney Int (1990) 1.10
Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography. J Clin Oncol (2001) 1.07
PET for in vivo pharmacokinetic and pharmacodynamic measurements. Eur J Cancer (2002) 1.06
Hypoxia in head and neck cancer. Br J Radiol (2006) 1.04
In situ hybridization of chromosome loci. Fed Proc (1975) 1.04
A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy. Br J Cancer (2012) 0.98
Tumour inoculation during laparoscopy. Lancet (1993) 0.98
Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials. Cancer Res (1997) 0.97
Radiosensitivity, radiogenomics and RAPPER. Clin Oncol (R Coll Radiol) (2006) 0.96
Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARF. Kidney Int (1989) 0.96
Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Br J Cancer (2007) 0.91
In situ hybridization for gene mapping. Cytogenet Cell Genet (1975) 0.91
Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action. Lancet (2000) 0.90
The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol (2006) 0.90
Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review. Clin Otolaryngol (2007) 0.88
Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer. Cancer Res (2001) 0.88
Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms. Radiother Oncol (1996) 0.87
Studies of the copper-binding proteins in Menkes and normal cultured skin fibroblast lysates. J Cell Physiol (1981) 0.87
Clinical impact of tumour involvement of the anastomotic doughnut in oesophagogastric cancer surgery. Ann R Coll Surg Engl (2009) 0.87
Plasma pharmacokinetic evaluation of cytotoxic agents radiolabelled with positron emitting radioisotopes. Cancer Chemother Pharmacol (2007) 0.86
Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa. J Clin Oncol (1999) 0.86
Positron emission tomographic imaging of angiogenesis and vascular function. Br J Radiol (2003) 0.86
Head and neck cancer-part 1: epidemiology, presentation, and preservation. Clin Otolaryngol (2011) 0.86
In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography. Br J Cancer (2004) 0.86
Replicative intermediate of hepatitis B virus in transfected murine fibroblasts. J Virol (1987) 0.86
Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sample. Int J Oncol (2005) 0.85
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix. Br J Cancer (2009) 0.85
Positron emission tomography imaging of cell proliferation in oncology. Clin Oncol (R Coll Radiol) (2004) 0.85
Two routes to [11C-carbonyl]organo-isocyanates utilizing [11C]phosgene ([11C]organo-isocyanates from [11C]phosgene). Nucl Med Biol (2001) 0.84
Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery. Dis Esophagus (2012) 0.83
Ingestion of a quadhelix appliance requiring surgical removal: a case report. J Orthod (2007) 0.83
Ultrastructural studies of fibroblasts transfected with hepatitis B virus DNA. Hepatology (1984) 0.83
How does dietary lipid lower blood alcohol concentrations? Gut (1986) 0.82
How often does maternal preeclampsia-eclampsia incite thrombocytopenia in the fetus? Obstet Gynecol (1987) 0.82
The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy. Br J Cancer (2010) 0.82
Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix. Br J Cancer (2005) 0.81
Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer. Clin Oncol (R Coll Radiol) (2010) 0.81
DNA synthesis is dissociated from the immediate-early gene response in the post-ischemic kidney. Kidney Int (1995) 0.81
Blood pressure response to estrogen-progestin oral contraceptive after pregnancy-induced hypertension. Am J Obstet Gynecol (1977) 0.81
Trends in organ donation. Clin Transplant (1998) 0.81
Assessment of the technology for functional imaging in cancer. Eur J Cancer (2002) 0.81
Combined endoscopic and laparoscopic approach for palliative resection of metastatic melanoma of the stomach. World J Surg Oncol (2006) 0.80
In situ hybridization for gene mapping. Birth Defects Orig Artic Ser (1975) 0.80
Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy. Clin Oncol (R Coll Radiol) (2012) 0.80
Cloning and sequencing of the rat preproepidermal growth factor cDNA: comparison with mouse and human sequences. DNA Cell Biol (1992) 0.79
Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants. Vaccine (1995) 0.78
Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues. Cancer Res (2001) 0.78
Ureteral obstruction decreases renal prepro-epidermal growth factor and Tamm-Horsfall expression. Kidney Int (1992) 0.78
Short report: a morbidity scoring system for Clinical Oncology practice: questionnaires produced from the LENT SOMA scoring system. Clin Oncol (R Coll Radiol) (2002) 0.78
On the development of rational standards for nuclear response evaluation. Q J Nucl Med (2003) 0.77
Erythroplasia of Queyrat treated with isotretinoin. Lancet (1993) 0.77
Sources of error in tissue and tumor measurements of 5-[18F]fluorouracil. J Nucl Med (1998) 0.76
The effect of two alpha 2-adrenoreceptor agonists and an antagonist on gastric emptying and mouth to caecum transit time in humans. Aliment Pharmacol Ther (1987) 0.76
Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET. Curr Pharm Des (2001) 0.76
Development and validation of a variance model for dynamic PET: uses in fitting kinetic data and optimizing the injected activity. Phys Med Biol (2010) 0.76
In vivo monitoring of drugs using radiotracer techniques. Adv Drug Deliv Rev (2000) 0.76
Urine odor eliminators. J Am Vet Med Assoc (1989) 0.75
In situ hybridization of RD114-virus RNA with human metaphase chromosomes. Proc Natl Acad Sci U S A (1973) 0.75